CD8A and hepatocellular carcinoma: In summary, by using PDTF platform, we demonstrated that higher infiltration of stem-like CD8+ Tpex was associated with better early T + A treatment efficacy in HCC, which has great clinical value for guiding T + A treatment application and improving the efficacy of T + A treatment in HCC patients in the future.